Triodos Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.8M | Buy |
|
|||||
|
2025
Q1 | $36M | Sell |
|
|||||
|
2024
Q4 | $37.8M | Buy |
|
|||||
|
2024
Q3 | $33.6M | Buy |
|
|||||
|
2024
Q2 | $37.7M | Hold |
|
|||||
|
2024
Q1 | $39M | Buy |
|
|||||
|
2023
Q4 | $28.1M | Sell |
|
|||||
|
2023
Q3 | $25.9M | Sell |
|
|||||
|
2023
Q2 | $36.9M | Sell |
|
|||||
|
2023
Q1 | $32.6M | Sell |
|
|||||
|
2022
Q4 | $29.8M | Sell |
|
|||||
|
2022
Q3 | $38M | Buy |
|
|||||
|
2022
Q2 | $39M | Buy |
|
|||||
|
2022
Q1 | $48.2M | Hold |
|
|||||
|
2021
Q4 | $53.1M | Buy |
|
|||||
|
2021
Q3 | $44.9M | Sell |
|
|||||
|
2021
Q2 | $41.8M | Buy |
|
|||||
|
2021
Q1 | $33.7M | Buy |
|
|||||
|
2020
Q4 | $34.2M | Buy |
|
|||||
|
2020
Q3 | $28.7M | Buy |
|
|||||
|
2020
Q2 | $19.5M | Sell |
|
|||||
|
2020
Q1 | $19.8M | Buy |
|
|||||
|
2019
Q4 | $18.9M | Sell |
|
|||||
|
2019
Q3 | $17.9M | Sell |
|
|||||
|
2019
Q2 | $20.3M | Sell |
|
|||||
|
2019
Q1 | $22.7M | Sell |
|
|||||
|
2018
Q4 | $19.9M | Sell |
|
|||||
|
2018
Q3 | $29M | Sell |
|
|||||
|
2018
Q2 | $25.5M | Buy |
|